Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31415563.
- Also identified by DOI 10.1371/journal.pmed.1002882 and PMC identifier 6695091.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Amita Gupta and colleagues discuss priorities in clinical research aimed at improving tuberculosis prevention and treatment in pregnant women, children, and people with HIV.
Medical subject headings
- Antitubercular Agents
- Clinical Trials as Topic
- HIV Infections
- Patient Selection
- Pregnancy Complications, Infectious
- Tuberculosis, Pulmonary